Home
/
Verrica Pharmaceuticals Inc.
/
Financials
/
Quarterly
Verrica Pharmaceuticals Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Verrica Pharmaceuticals Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$14.34M
Nov 14, 2025
Q3
2025
Sep 30, 2024
($1.78M)
Nov 14, 2025
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2025
Jun 30, 2025
$12.70M
Aug 12, 2025
Q1
2025
Mar 31, 2025
$3.44M
May 13, 2025
Q3
2024
Sep 30, 2024
($1.78M)
Nov 5, 2024
Q2
2025
Jun 30, 2024
$5.18M
Aug 12, 2025
Q1
2025
Mar 31, 2024
$3.83M
May 13, 2025
Q3
2024
Sep 30, 2023
$2.92M
Nov 5, 2024
Q2
2024
Jun 30, 2023
$182.0K
Aug 14, 2024
Q1
2024
Mar 31, 2023
$37.0K
May 13, 2024
Q3
2023
Sep 30, 2022
$8.32M
Nov 9, 2023
Q2
2023
Jun 30, 2022
$214.0K
Aug 8, 2023
Q1
2023
Mar 31, 2022
$431.0K
May 9, 2023
Q3
2022
Sep 30, 2021
$0
Nov 7, 2022
Q2
2022
Jun 30, 2021
$0
Aug 11, 2022
Q1
2022
Mar 31, 2021
$12.00M
May 9, 2022
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($274.0K)
Nov 14, 2025
Q3
2025
Jun 30, 2025
$204.0K
Nov 14, 2025
Q2
2025
Jun 30, 2025
$204.0K
Aug 12, 2025
Q2
2025
Mar 31, 2025
($9.74M)
Aug 12, 2025
Q1
2025
Mar 31, 2025
($9.74M)
May 13, 2025
Q3
2025
Mar 31, 2025
($9.74M)
Nov 14, 2025
Q3
2025
Sep 30, 2024
($22.86M)
Nov 14, 2025
Q3
2025
Jun 30, 2024
($17.19M)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($17.19M)
Aug 12, 2025
Q1
2025
Mar 31, 2024
($20.33M)
May 13, 2025
Q2
2025
Mar 31, 2024
($20.33M)
Aug 12, 2025
Q3
2025
Mar 31, 2024
($20.33M)
Nov 14, 2025
Q3
2024
Sep 30, 2023
($24.80M)
Nov 5, 2024
Q2
2024
Jun 30, 2023
($10.99M)
Aug 14, 2024
Q3
2024
Jun 30, 2023
($10.99M)
Nov 5, 2024
Q1
2024
Mar 31, 2023
($6.59M)
May 13, 2024
Q2
2024
Mar 31, 2023
($6.59M)
Aug 14, 2024
Q3
2024
Mar 31, 2023
($6.59M)
Nov 5, 2024
Q3
2023
Sep 30, 2022
$83.0K
Nov 9, 2023
Q2
2023
Jun 30, 2022
($10.17M)
Aug 8, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$1.63M
Nov 14, 2025
Q2
2025
Jun 30, 2025
$1.51M
Aug 12, 2025
Q1
2025
Mar 31, 2025
($8.13M)
May 13, 2025
Q3
2025
Sep 30, 2024
($20.70M)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($15.21M)
Aug 12, 2025
Q1
2025
Mar 31, 2024
($18.60M)
May 13, 2025
Q3
2024
Sep 30, 2023
($23.92M)
Nov 5, 2024
Q2
2024
Jun 30, 2023
($11.62M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($7.09M)
May 13, 2024
Q3
2023
Sep 30, 2022
$1.45M
Nov 9, 2023
Q2
2023
Jun 30, 2022
($9.12M)
Aug 8, 2023
Q1
2023
Mar 31, 2022
($7.41M)
May 9, 2023
Q3
2022
Sep 30, 2021
($11.77M)
Nov 7, 2022
Q2
2022
Jun 30, 2021
($10.73M)
Aug 11, 2022
Q1
2022
Mar 31, 2021
$60.0K
May 9, 2022
Q3
2021
Sep 30, 2020
($9.64M)
Nov 12, 2021
Q2
2021
Jun 30, 2020
($8.63M)
Aug 10, 2021
Q1
2021
Mar 31, 2020
($9.88M)
May 7, 2021
Q3
2020
Sep 30, 2019
($6.54M)
Nov 9, 2020
Q2
2020
Jun 30, 2019
($7.52M)
Aug 5, 2020